Safety and efficacy of zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (magnolia phase 2 study)
dc.contributor.author | Tedeschi, A. | |
dc.contributor.author | Trotman, J. | |
dc.contributor.author | Zinzani, P. | |
dc.contributor.author | Cavallo, F. | |
dc.contributor.author | Marasca, R. | |
dc.contributor.author | Liberati, A. | |
dc.contributor.author | Linton, Kim M | |
dc.contributor.author | McKay, P. | |
dc.contributor.author | Hu, B. | |
dc.contributor.author | Coleman, M. | |
dc.contributor.author | Ardeshna, K. | |
dc.contributor.author | Bijou, F. | |
dc.contributor.author | Marcus, R. | |
dc.contributor.author | Portell, C. | |
dc.contributor.author | Thieblemont, C. | |
dc.contributor.author | Bachy, E. | |
dc.contributor.author | Costello, R. | |
dc.contributor.author | Iyengar, S. | |
dc.contributor.author | Mocikova, H. | |
dc.contributor.author | Co, M. | |
dc.contributor.author | Li, X. | |
dc.contributor.author | Zhou, W. | |
dc.contributor.author | Cappellini, M. | |
dc.contributor.author | Tankersley, C. | |
dc.contributor.author | Huang, J. | |
dc.contributor.author | Opat, S. | |
dc.date.accessioned | 2022-01-11T12:00:17Z | |
dc.date.available | 2022-01-11T12:00:17Z | |
dc.date.issued | 2021 | en |
dc.identifier.citation | Tedeschi A, Trotman J, Zinzani P, Cavallo F, Marasca R, Liberati A, et al. SAFETY AND EFFICACY OF ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MAGNOLIA PHASE 2 STUDY). Haematologica. 2021;106(10):35-. | en |
dc.identifier.uri | http://hdl.handle.net/10541/624991 | |
dc.title | Safety and efficacy of zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (magnolia phase 2 study) | en |
dc.type | Article | en |
dc.contributor.department | ASST Grande Ospedale Metropolitano Niguarda; | en |
dc.identifier.journal | Haematologica | en |
dc.description.note | en] |